These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30262431)

  • 21. Characterization of the Shiga toxin-producing Escherichia coli O26 isolated from human in Poland between 1996 and 2014.
    Januszkiewicz A; Wołkowicz T; Chróst A; Szych J
    Lett Appl Microbiol; 2015 Jun; 60(6):605-8. PubMed ID: 25758912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ampicillin, gentamicin, and cefotaxime on the release of Shiga toxins from Shiga toxin-producing Escherichia coli isolated during a diarrhea episode in Faisalabad, Pakistan.
    Mohsin M; Haque A; Ali A; Sarwar Y; Bashir S; Tariq A; Afzal A; Iftikhar T; Saeed MA
    Foodborne Pathog Dis; 2010 Jan; 7(1):85-90. PubMed ID: 19785532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of Escherichia coli encoding Shiga toxin 2f in human Shiga toxin-producing E. coli (STEC) infections in the Netherlands, January 2008 to December 2011.
    Friesema I; van der Zwaluw K; Schuurman T; Kooistra-Smid M; Franz E; van Duynhoven Y; van Pelt W
    Euro Surveill; 2014 May; 19(17):26-32. PubMed ID: 24821123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virulent gene profile and antibiotic susceptibility pattern of Shiga toxin-producing Escherichia coli (STEC) from cattle and camels in Maiduguri, North-Eastern Nigeria.
    Adamu MS; Ugochukwu ICI; Idoko SI; Kwabugge YA; Abubakar NS; Ameh JA
    Trop Anim Health Prod; 2018 Aug; 50(6):1327-1341. PubMed ID: 29564631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic-resistant Shiga toxin-producing Escherichia coli: An overview of prevalence and intervention strategies.
    Mir RA; Kudva IT
    Zoonoses Public Health; 2019 Feb; 66(1):1-13. PubMed ID: 30375197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epidemiological investigation of Shiga toxin-producing Escherichia coli isolates originated from healthy sheep in one farm of Jiangsu Province and their pathogenicity].
    Gu C; Xue T; Xu T; Gao S; Jiao X; Liu X
    Wei Sheng Wu Xue Bao; 2011 May; 51(5):676-83. PubMed ID: 21800631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variable tellurite resistance profiles of clinically-relevant Shiga toxin-producing Escherichia coli (STEC) influence their recovery from foodstuffs.
    Kerangart S; Douëllou T; Delannoy S; Fach P; Beutin L; Sergentet-Thévenot D; Cournoyer B; Loukiadis E
    Food Microbiol; 2016 Oct; 59():32-42. PubMed ID: 27375242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of shiga-toxigenic Escherichia coli (STEC) in diarrhoeagenic stool & meat samples in Mangalore, India.
    Dhanashree B; Mallya PS
    Indian J Med Res; 2008 Sep; 128(3):271-7. PubMed ID: 19052337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shiga toxin-producing Escherichia coli in drinking water supplies of north Paraná State, Brazil.
    Lascowski KM; Guth BE; Martins FH; Rocha SP; Irino K; Pelayo JS
    J Appl Microbiol; 2013 Apr; 114(4):1230-9. PubMed ID: 23279284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biofilm-Forming Abilities of Shiga Toxin-Producing Escherichia coli Isolates Associated with Human Infections.
    Vogeleer P; Tremblay YDN; Jubelin G; Jacques M; Harel J
    Appl Environ Microbiol; 2015 Dec; 82(5):1448-1458. PubMed ID: 26712549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic resistance and integrons in Shiga toxin-producing Escherichia coli (STEC).
    Colello R; Etcheverría AI; Di Conza JA; Gutkind GO; Padola NL
    Braz J Microbiol; 2015 Mar; 46(1):1-5. PubMed ID: 26221083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel sequence types of non-O157 Shiga toxin-producing Escherichia coli isolated from cattle.
    Isiko J; Khaitsa M; Bergholz TM
    Lett Appl Microbiol; 2015 Jun; 60(6):552-7. PubMed ID: 25702803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of Shiga toxin-producing Escherichia coli (STEC) in retail edible beef by-products.
    Lee JH; Hyeon JY; Kim YG; Chon JW; Park JH; Park C; Choi IS; Kim SK; Seo KH
    Foodborne Pathog Dis; 2012 Feb; 9(2):145-9. PubMed ID: 22168214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virulence characteristics of Shiga toxin-producing Escherichia coli from raw meats and clinical samples.
    Hoang Minh S; Kimura E; Hoang Minh D; Honjoh K; Miyamoto T
    Microbiol Immunol; 2015 Mar; 59(3):114-22. PubMed ID: 25644201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved detection of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli in input and output samples of German biogas plants by a selective pre-enrichment procedure.
    Schauss T; Glaeser SP; Gütschow A; Dott W; Kämpfer P
    PLoS One; 2015; 10(3):e0119791. PubMed ID: 25799434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug resistance profile and molecular characterization of extended spectrum beta-lactamase (ESβL)-producing Pseudomonas aeruginosa isolated from burn wound infections. Essential oils and their potential for utilization.
    El-Shouny WA; Ali SS; Sun J; Samy SM; Ali A
    Microb Pathog; 2018 Mar; 116():301-312. PubMed ID: 29407236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenic potential to humans of Shiga toxin-producing Escherichia coli isolated from wild boars in Poland.
    Szczerba-Turek A; Socha P; Bancerz-Kisiel A; Platt-Samoraj A; Lipczynska-Ilczuk K; Siemionek J; Kończyk K; Terech-Majewska E; Szweda W
    Int J Food Microbiol; 2019 Jul; 300():8-13. PubMed ID: 30991235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shiga Toxin-Producing
    Bai X; Mernelius S; Jernberg C; Einemo IM; Monecke S; Ehricht R; Löfgren S; Matussek A
    Front Cell Infect Microbiol; 2018; 8():125. PubMed ID: 29765909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidrug-Resistant Sequence Type 235 Pseudomonas aeruginosa Clinical Isolates Producing IMP-26 with Increased Carbapenem-Hydrolyzing Activities in Vietnam.
    Tada T; Nhung PH; Miyoshi-Akiyama T; Shimada K; Tsuchiya M; Phuong DM; Anh NQ; Ohmagari N; Kirikae T
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6853-6858. PubMed ID: 27600046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.